Craig Moy
Consultant
Craig has over 30 years’ experience in business development and commercialisation across Australia, Asia and the USA. Working exclusively with blue chip multinationals including Zimmer, Johnson & Johnson and Smith and Nephew, with the last 3 years as ANZ GM for Smith & Nephew. Craig has a passion for all elements of the business cycle having led teams in product ideation, engineering and development, clinical research, health outcomes, compliance, market access including optimised pricing, through downstream sales, marketing and operations.
He represented the device industry (MTAA) on a number of government Committees and reviews, including the 2015 roundtables on value in the private health insurance sector. In recent years he led the biotech commercialisation efforts at the Garvan Institute of Medical Research including framing the federal government $500M commitment to precision medicine and genomics announced in the 2018/19 federal budget.
Craig was a consultant for the Department of Health and is currently engaged by Private Healthcare Australia, Australia’s private health insurance representative body. Craig is a prior ministerial appointed member of the Prosthetic Listing Advisory Committee and serves as the health insurance industry representative on industry working groups for device reform.